Joliet、ILにおける肺がんの臨床試験
Jolietとその周辺地域（約30マイル以内）の拠点で、肺がんに関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6マイル先
- University of Chicago Medicine-Orland Park, Orland Park · 14マイル先
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
被験者募集中第3相
- Northwestern Medicine Orland Park, Orland Park · 14マイル先
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
被験者募集中第3相
- Northwestern Medicine Orland Park, Orland Park · 14マイル先
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
被験者募集中第2相
- Hope and Healing Clinical Research, New Lenox · 6マイル先
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Hope and Healing Cancer Services, New Lenox · 6マイル先
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
被験者募集中第3相
- Hope and Healing Cancer Services, New Lenox · 6マイル先
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
被験者募集中第2相
- Hope and Healing Clinical Research, New Lenox · 6マイル先
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
被験者募集中第1/2相
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6マイル先
- University of Chicago Medicine-Orland Park, Orland Park · 14マイル先
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- University of Chicago, New Lenox · 6マイル先
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Orland Park, Orland Park · 14マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Northwestern Medicine Orland Park, Orland Park · 14マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Orland Park, Orland Park · 14マイル先
他の都市における肺がんの試験
- Houston, TX78件の研究
- Boston, MA62件の研究
- New York City, NY60件の研究
- Los Angeles, CA45件の研究
- Arlington, VA41件の研究
- Washington, DC41件の研究
- Chicago, IL41件の研究
- Baltimore, MD40件の研究
- Nashville, TN40件の研究
- St. Louis, MO39件の研究
- Columbus, OH37件の研究
- Philadelphia, PA36件の研究
Jolietにおける他の研究
- 非小細胞肺癌12件の研究
- 膀胱癌7件の研究
- 転移性癌7件の研究
- 頭頸部扁平上皮癌6件の研究
- 前立腺がん5件の研究
- 急性骨髄性白血病5件の研究
- 下咽頭がん5件の研究
- 喉頭がん5件の研究
- 口腔がん5件の研究
- 乳がん4件の研究
- 卵巣がん4件の研究
- 結腸癌4件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。